An observational study in Assisted Suicide, sponsored by National Institutes of Health Clinical Center (CC). Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by National Institutes of Health Clinical Center (CC) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 118 studies in Death with a site in United States — 13 open to participants now, 27 under way, 1 of them phase 3. Death · United States.
Among the 118 studies in Death with a site in United States, this one is the 33rd largest by enrollment of the 39 observational ones that give a count, is one of 9 that started in 2020, is one of 39 observational ones, reaches primary completion later than 11 of the 26 other live ones, and was the 74th registered.
457 studies on the registry are indexed under Death; 85 are open to participants now.
Browse Death studies →13 of the 118 studies in Death with a site in United States are open now. Recruiting first, the newest first:
University of Michigan · Sites in United States
Ages 18+
University of Illinois at Chicago · Sites in United States
Ages 18–80
Massachusetts General Hospital · Sites in United States
Yaolin Pei · Sites in United States
Ages 21–99
Fred Hutchinson Cancer Center · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 58 Death studies recruiting now, 43 (74%) set no upper age limit and 8 (14%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
118 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 4 · Phase 3 6 · Phase 4 1
First in 1980; this study’s year is marked. 9 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 25 is below the median of 400 across 236 observational studies indexed under Death.
Median enrollment 154 across the 79 interventional studies, 272 across the 39 observational. Of the 78 that completed or were terminated, 17 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 118 have an industry lead sponsor. The 10 most frequent:
National Institutes of Health Clinical Center (CC) is the lead sponsor of 376 studies on the registry; 27 are open to participants now.
Of its 23 completed or terminated interventional studies of FDA-regulated products, 19 (83%) have results posted.
National Institutes of Health Clinical Center (CC) has 2 studies filed under Death — fewer than ten, so there is no comparison to draw.
7 of the studies in Death with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06293456Memorial Sloan Kettering Cancer CenterStudy of Poetic Dignity Therapy for Sexual and Gender Minority Patients With Cancer | 2027-01 |
| NCT04261088National Institutes of Health Clinical Center (CC)Assisted Suicide in Switzerland | 2027-01-31 |
| NCT05446272University of PennsylvaniaThe Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial | 2027-03-31 |
| NCT04515810Fred Hutchinson Cancer CenterMobile Health Application (PACT) to Improve Engagement in Advance Care Planning | 2027-05-31 |
| NCT07370311Yaolin PeiA Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisions | 2027-07-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 118 studies in Death with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Background:
Researchers want to learn more about how the Swiss model of assisted suicide works. To do this, they have interviewed 25 Swiss experts. The researchers will draw on research in the fields of ethics, law, and medicine to analyze the transcripts.
Objective:
To describe the practice of assisted suicide in Switzerland and to study how the policy is carried out, how the right-to-die societies work, and the ethical implications of the practice.
Eligibility:
Swiss experts in the field of assisted suicide
Design:
The study includes 25 interviews that have already been conducted. The participants were:
Researchers will analyze the data using qualitative methods. Two researchers will develop a coding scheme and code the texts and analyze the data.
Switzerland is the only country in the world that enables assisted suicide by lay people, i.e.,
people who are not physicians. All other countries that have adopted aid-in-dying legislation
require that a physician provides this assistance. This project probes the reasons for adopting this policy, and the advantages and the disadvantages of the Swiss model at the end of life. Are the Swiss aid-in-dying volunteers able to provide well-informed assistance to patients in need? Is the Swiss model one to be followed by other nations? The project will focus on the work of the Swiss aid-in-dying societies. The study draws on research in the fields of ethics, law and medicine. Its novelty lies in incorporating different methods of analysis, reflecting on the right to die with dignity within a liberal framework that aims to respect fundamental human rights.
25 transcripts of interviews with: Academics 14, Physicians and other medical care 6, Right to die associations 4, Government official 1
The study includes 25 interviews with Swiss experts that have been conducted.
Persons in Switzerland who are experts in how assisted suicide is practiced. We will beexamining already collected interviews.
Descriptive study
This is a qualitative descriptive study of transcripts.
Time frame: Ongoing
Started Feb 2020 (actual). Primary completion is estimated for Jan 2027, 83 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Institutes of Health Clinical Center (CC) →